Brief: Biomx Reports Fourth Quarter And Full Year 2022 Financial Results
March 29 (Reuters) - Biomx Inc PHGE.A :
* BIOMX REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* BIOMX INC - CASH RUNWAY THROUGH AT LEAST MID-2024
* BIOMX INC - PATIENT ENROLLMENT CONTINUES IN PART 2 OF
PHASE
1B/2A TRIAL WITH RESULTS EXPECTED IN Q3 OF 2023
* BIOMX INC - ANNOUNCED POSITIVE RESULTS FROM PART 1 OF
ONGOING
PHASE 1B/2A TRIAL OF BX004 FOR TREATMENT OF LUNG INFECTIONS IN
CYSTIC FIBROSIS ("CF")
* BIOMX INC - CASH BALANCE, SHORT-TERM DEPOSITS AND
RESTRICTED
CASH AS OF DECEMBER 31, 2022, WERE $34.3 MILLION
Source text for Eikon: ID:nGNX7bDTxw
Further company coverage: PHGE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tessera Defense and Homeland Security
See all newsBrief: Tessera Subsidiary Zorronet Expands D4P Group Collaboration Into AI-Powered Critical Infrastructure And Homeland Security Markets Across The EU
Brief: Tessera Defense & Homeland Security - Enters $5 Million Revolving Credit Agreement With Mandragola On Oct 5, 2026 - SEC Filing
Brief: Biomx - Announces One-For-Ten Reverse Stock Split Of Common Stock - SEC Filing
Brief: Biomx And Water.Io Agree To Updated Zorronet Acquisition Terms
Brief: BiomX - May Offer And Sell Up To $9.10 Million Of Common Stock Through Wainwright - SEC Filing